Skip to main content
. Author manuscript; available in PMC: 2021 Aug 24.
Published in final edited form as: Colorectal Dis. 2020 Jun 14;22(10):1314–1324. doi: 10.1111/codi.15113

Table 4. Additional treatments.

(a) Numbers of patients and cycles of chemotherapy
Group    N      Treated Cycles Median Total cycles
Control    47      23 (49%) 1–6 3 68
Metastasectomy    46      19 (41%) 2–7 3 60
(b) Timing from randomisation in months
Group N < 6*      6–12      Earliest      Median IQR
Control 47 9      3      0.4      11.6 2.3–16.4
Metastasectomy 46 6      7      1.0      7.8 5.4–14.1
(c) Radiotherapy and IGTA in months
Radiotherapy    N          < 6     6–12     > 12 Total
Control    47          0     1     3   4
Metastasectomy    46          0     1     4   5
IGTA N < 6       6–9       9–12       > 12 Total
Control 47 0       1       1       1   3
Metastasectomy 46 0       1       1       0   2
*

Any differences may in part reflect considerations of fitness for chemotherapy in the post-operative period.